Q3 2022 BICO Group AB Earnings Call Transcript
()-- -
Hello, and thank you for taking the time today. I would like to give you a very warm welcome to BICO Group 2022 Q3 Earnings Call. My name is Erik Gatenholm, President and CEO, here at BICO. And today, I'm here with our interim CFO, Mikael Engblom.
The purpose of this call is to present our Q3 financial results and provide a business update for BICO Group. It's a pleasure working with everyone in our team and serving the continuous growing needs of the life science industry around the world and through persistence and resilience manage the conditions in this uncertain macro economy. 2022 has been a turbulent year for many growth companies, but I believe that we're making good progress aligning the business towards a more profitable and cash flow-oriented way of working.
And while many important products are still in progress, I'm proud to see us take the right steps in the right direction. BICO's mission is to enable the pharmaceutical and biopharma
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |